Global Neurological Biomarkers Market Set to Triple to $31.82 Billion by 2034
• The neurological biomarkers market is projected to grow from $9.45 billion in 2024 to $31.82 billion by 2034, with a CAGR of 12.91%, driven by rising neurological disorder prevalence and increased R&D funding.
• Proteomic biomarkers currently dominate with 30.49% market share, while Alzheimer's disease applications lead the segment, with Parkinson's disease applications expected to show substantial growth through 2034.
• North America maintains market leadership with 42% share, while Asia Pacific is poised for the fastest growth rate due to rising disposable income, aging populations, and increasing neurological disorder incidence in emerging economies.
Evaluation of One Step Nucleic Acid Amplification for Detection of Lymph Node Metastases in Endometrial Cancer
A new study evaluates the effectiveness of One Step Nucleic Acid Amplification (OSNA) in detecting lymph node metastases in endometrial cancer, comparing it to the traditional ultrastaging method. The study aims to provide a faster, standardized analysis of lymph nodes, potentially expediting patient treatment and management.
© Copyright 2025. All Rights Reserved by MedPath